NB
Navneet Bansal
About Navneet Bansal
Data last updated:
Navneet Bansal is a Director at Novolilly Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Novolilly Pharmaceutical Private Limited reported revenue of ₹2.21 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novolilly Pharmaceutical Private Limited U24299HR2021PTC095493 | Director | 08 Jun 2021 | 2021 | ₹2.21 Cr (FY 2024) | Active |
Board colleagues of Navneet Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gomeda Bansal | 09443912 | Novolilly Pharmaceutical Private Limited | Additional Director |
| Vaneet Jain | 01841135 | Novolilly Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navneet Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navneet Bansal
Navneet Bansal currently holds 1 directorship: Novolilly Pharmaceutical Private Limited (Director, since 08 Jun 2021, revenue ₹2.21 Cr (FY 2024)).
Navneet Bansal was first appointed on 08 Jun 2021 as Director at Novolilly Pharmaceutical Private Limited.
The current boards of Navneet Bansal's companies include Gomeda Bansal (Novolilly Pharmaceutical Private Limited), Vaneet Jain (Novolilly Pharmaceutical Private Limited).